Open access
2025
Journal of Population Therapeutics and Clinical Pharmacology
Evaluating the diagnostic accuracy of Nkx3.1 as a diagnostic performance in a combination with p63 and AMACR in prostatic adenocarcinoma proves to be significant, and in suspected situations, IHC is advised to minimise diagnostic error.
Ekta Bhushan, R. Nimbargi, Priyanka Yadav et al.
· 0 citations